• FDNA offers labs and bioinformatics companies access to data and technology that add a new dimension to standard variant analysis, increasing the diagnostic yield while saving time and money. FDNA technology uses computer vision, deep learning and artificial intelligence to capture and analyze detailed phenotypic information from patients. The phenotypic data and insights can be easily integrated with the lab’s bioinformatics system to enhance molecular interpretation.

Long waits and high costs plague the interpretation of WES (whole exome sequencing) and WGS (whole genome sequencing) while the diagnostic yield remains very low. The greatest obstacle to finding a molecular diagnosis is filtering out gene variants that result from sequencing errors, while highlighting the true variants that are both disease causing and are showing clinical manifestation in the patient.

FDNA’s Face2Gene Suite is being used by clinicians globally to capture structured phenotype and genotype information, producing a list of syndromes, symptoms and genes with a unique scoring method. This information is available to labs and bioinformatics through a free and secure API, easily and instantly adding a new dimension to interpretation pipelines.

Our Products for
Labs and Bioinformatic Companies

Genetic Variant Prioritization Supported by Next-Generation Phenotyping

Face2Gene LABS enhances the interpretation of genomic test results by enabling clinicians to send detailed patient phenotype information, medical annotations and deep learning insights directly into the molecular interpretation pipeline, highlighting clinically-relevant genetic variants to consider.


Structured Phenotypes and Insights Direct to Lab

Face2Gene CONNECT adds a dimension to variant filtering with phenotype sequencing. Using structured phenotypes and insights provided directly from clinicians through a secure API, labs are better able to prioritize variants and make molecular diagnoses.

Contact us to get the api
See the API technical document >